Optic nerve glioma historical perspective: Difference between revisions

	Optic nerve glioma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Optic nerve glioma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Optic nerve glioma historical perspective On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Optic nerve glioma historical perspective All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Optic nerve glioma historical perspective
CDC on Optic nerve glioma historical perspective
Optic nerve glioma historical perspective in the news
Blogs on Optic nerve glioma historical perspective
Directions to Hospitals Treating Optic nerve glioma
Risk calculators and risk factors for Optic nerve glioma historical perspective

Revision as of 18:58, 9 October 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Optic nerve glioma was first described in 1816 by Scarpa.^[1]

Optic nerve glioma was first described in 1816 by Scarpa.

↑ Tasman W, Jaeger EA. Duane's Ophthalmology on CD-ROM, 2001 Edition. Philadelphia : Lippincott Williams & Wilkins, 2006.; 2001.

@@ Line 5: / Line 5: @@
 Optic nerve glioma was first described in 1816 by Scarpa.<ref>Tasman W, Jaeger EA. Duane's Ophthalmology on CD-ROM, 2001 Edition. Philadelphia : Lippincott Williams & Wilkins, 2006.; 2001.</ref>
 ==Historical Perspective==
-Optic pathway gliomas are glial tumors that can affect the optic nerves, chiasm, tracts, and radiations, as well as adjacent neurologic structures. Since Scarpa first described an optic nerve glioma in 1816,1 many case reports and reviews have followed in order to characterize these lesions further. There is considerable controversy in the literature over the biologic behavior and optimum therapy for these tumors. Recent large literature reviews have proved to be valuable resources when considering management of patients with optic glioma. The reader is directed to excellent reviews conducted by Alvord and Lofton2 in 1988, and most recently by Dutton3 in 1994. After discussing the clinical features and diagnostic appearance of optic pathway gliomas, this chapter will provide an overview of various treatment regimens. Attention will then be directed to a different entity, the rare malignant optic glioma of adulthood, which is both aggressive and lethal.
+Optic nerve glioma was first described in 1816 by Scarpa.
 ==References==
 {{Reflist|2}}